These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 20144246)

  • 1. A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial.
    Ligaarden SC; Axelsson L; Naterstad K; Lydersen S; Farup PG
    BMC Gastroenterol; 2010 Feb; 10():16. PubMed ID: 20144246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics Ameliorate Stool Consistency in Patients with Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Study.
    Yoon JY; Cha JM; Oh JK; Tan PL; Kim SH; Kwak MS; Jeon JW; Shin HP
    Dig Dis Sci; 2018 Oct; 63(10):2754-2764. PubMed ID: 29876777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and dose response of
    Martoni CJ; Srivastava S; Damholt A; Leyer GJ
    World J Gastroenterol; 2023 Jul; 29(28):4451-4465. PubMed ID: 37576702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical trial: effect of Lactobacillus plantarum 299 v on symptoms of irritable bowel syndrome.
    Stevenson C; Blaauw R; Fredericks E; Visser J; Roux S
    Nutrition; 2014 Oct; 30(10):1151-7. PubMed ID: 25194614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome.
    Ducrotté P; Sawant P; Jayanthi V
    World J Gastroenterol; 2012 Aug; 18(30):4012-8. PubMed ID: 22912552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acacia fiber or probiotic supplements to relieve gastrointestinal complaints in patients with constipation-predominant IBS: a 4-week randomized double-blinded placebo-controlled intervention trial.
    JanssenDuijghuijsen L; van den Belt M; Rijnaarts I; Vos P; Guillemet D; Witteman B; de Wit N
    Eur J Nutr; 2024 Aug; 63(5):1983-1994. PubMed ID: 38653808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised controlled trial of a probiotic 'functional food' in the management of irritable bowel syndrome.
    Roberts LM; McCahon D; Holder R; Wilson S; Hobbs FD
    BMC Gastroenterol; 2013 Mar; 13():45. PubMed ID: 23496803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life.
    Lorenzo-Zúñiga V; Llop E; Suárez C; Alvarez B; Abreu L; Espadaler J; Serra J
    World J Gastroenterol; 2014 Jul; 20(26):8709-16. PubMed ID: 25024629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth.
    Leventogiannis K; Gkolfakis P; Spithakis G; Tsatali A; Pistiki A; Sioulas A; Giamarellos-Bourboulis EJ; Triantafyllou K
    Probiotics Antimicrob Proteins; 2019 Jun; 11(2):627-634. PubMed ID: 29508268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea-predominant IBS.
    Hod K; Sperber AD; Ron Y; Boaz M; Dickman R; Berliner S; Halpern Z; Maharshak N; Dekel R
    Neurogastroenterol Motil; 2017 Jul; 29(7):. PubMed ID: 28271623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
    Ishaque SM; Khosruzzaman SM; Ahmed DS; Sah MP
    BMC Gastroenterol; 2018 May; 18(1):71. PubMed ID: 29801486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of New
    Oh JH; Jang YS; Kang D; Chang DK; Min YW
    Nutrients; 2019 Nov; 11(12):. PubMed ID: 31783597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of a Probiotic and an Antispasmodic Increases Quality of Life and Reduces Symptoms in Patients with Irritable Bowel Syndrome: A Pilot Study.
    Barraza-Ortiz DA; Pérez-López N; Medina-López VM; Minero-Alfaro JI; Zamarripa-Dorsey F; Fernández-Martínez NDC; Llorente-Ramón A; Ramos-Aguilar GA
    Dig Dis; 2021; 39(3):294-300. PubMed ID: 32810850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo.
    Lyra A; Hillilä M; Huttunen T; Männikkö S; Taalikka M; Tennilä J; Tarpila A; Lahtinen S; Ouwehand AC; Veijola L
    World J Gastroenterol; 2016 Dec; 22(48):10631-10642. PubMed ID: 28082816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study.
    Preston K; Krumian R; Hattner J; de Montigny D; Stewart M; Gaddam S
    Benef Microbes; 2018 Sep; 9(5):697-706. PubMed ID: 29888656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial.
    Choi CH; Kwon JG; Kim SK; Myung SJ; Park KS; Sohn CI; Rhee PL; Lee KJ; Lee OY; Jung HK; Jee SR; Jeen YT; Choi MG; Choi SC; Huh KC; Park H
    Neurogastroenterol Motil; 2015 May; 27(5):705-16. PubMed ID: 25809913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study.
    Sisson G; Ayis S; Sherwood RA; Bjarnason I
    Aliment Pharmacol Ther; 2014 Jul; 40(1):51-62. PubMed ID: 24815298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Probiotic Escherichia coli Nissle 1917 in Patients with Irritable Bowel Syndrome: a Double Blind Placebo-controlled Randomized Trial.
    Faghihi AH; Agah S; Masoudi M; Ghafoori SM; Eshraghi A
    Acta Med Indones; 2015 Jul; 47(3):201-8. PubMed ID: 26586385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.